The latest closing stock price for Alnylam Pharmaceuticals as of February 20, 2025 is 251.00.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $34,857 today, roughly 35 times their original investment - a 18.58% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 21.3% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.97, which is 43.4% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 224.34.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $34,857 today, roughly 35 times their original investment - a 18.58% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 21.3% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.97, which is 43.4% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 224.34.